10-K Decoder · All companies

Opus Genetics, Inc.

IRD · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$14.2M$11.0M+29.2%
Operating income−$38.6M−$62.1M+37.8%
Net income−$49.6M−$57.5M+13.8%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 10, 2026

$Q3 2026Year earlierChange
Revenue$1.10M$3.10M−64.5%
Operating income−$19.2M−$8.30M−131%
Net income−$46.5M−$17.5M−166%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Opus Genetics's revenue in FY2025?
$14.2M in FY2025 (Fiscal year ended Dec 31, 2025), +29.2% vs $11.0M a year earlier, per its 10-K filed Mar 2026.
Was Opus Genetics profitable in FY2025?
No: net income was −$49.6M and operating income −$38.6M in FY2025.
What was Opus Genetics's revenue in Q3 2026?
$1.10M (−64.5% vs a year earlier), per its Form 10-Q filed Nov 10, 2026.